are thought to have specific renoprotective effects in patients with diabetic and nondiabetic nephropathy. Some guidelines advocating the use of these drugs in renal disease, however, base their ...

In patients with obesity who also have type 2 diabetes and chronic kidney disease, surgery is a better renoprotective option ...

Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients ...

A high sodium intake inhibits the renoprotective effect of blockade of the renin–angiotensin–aldosterone system (RAAS). Vogt et al. investigated the combined effects of a low-sodium diet and ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

How strong is the evidence that these drugs are more renoprotective than other antihypertensive agents? In a meta-analysis, investigators reviewed 127 randomized controlled trials in which ACE ...

New research shows that metabolic bariatric surgery offers substantial protective benefits for patients with chronic kidney ...

Therapeutic Benefit of Fenofibrate in Diabetic Kidney Disease The renoprotective effects of fenofibrate may be due to its attenuation of lipid-related renal damage but also due to PPAR-α's ...

Melatonin, a hormone responsible for the sleep-wake circadian rhythm, proves to have some effects on kidney complications. Melatonin also plays a direct renoprotective role. Many studies say ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic ...

THE LATEST findings from the FLOW trial, the first dedicated kidney outcomes trial with semaglutide in patients with Type 2 diabetes (T2D) and chronic kidney disease (CKD), were presented at the ...